| Literature DB >> 28225052 |
D R Weber1, L J Stark2, R F Ittenbach2, V A Stallings3, B S Zemel3.
Abstract
BACKGROUND/Entities:
Mesh:
Substances:
Year: 2017 PMID: 28225052 PMCID: PMC5462896 DOI: 10.1038/ejcn.2017.5
Source DB: PubMed Journal: Eur J Clin Nutr ISSN: 0954-3007 Impact factor: 4.016
Figure 1Randomization and follow up of study participants
Baseline characteristics of 139 participants in a behavioral modification and nutritional educational (BM-NE) trial to improve calcium intake
| BM-NE Intervention | Usual Care | |
|---|---|---|
| 68 | 71 | |
| 43 (63.2) | 43 (60.6) | |
| 9 (7.2 to 11) | 9.1 (7.2 to 11) | |
| 19 (27.9) | 23 (32.4) | |
| 0 (0) | 1 (1.4) | |
| 54 (79.4) | 58 (81.7) | |
| 6 (8.8) | 5 (7.1) | |
| 35 (51.5) | 38 (53.5) | |
| 36 (52.9) | 47 (66.2) | |
| 0.17 ± 1.0 | 0.16 ± 0.94 | |
| 0.12 (−0.49–0.79) | 0.19 (−0.39–0.86) | |
| 61 (89.7) | 61 (87.1) | |
| 30.1 (24.5–36.1) | 30.4 (25.6–39.2) | |
| 75.1 (61.2–90.1) | 75.9 (63.9–97.8) | |
| 2.5 (1.5–3.3) | 2.3 (1.7–3.3) | |
| | 876 (735–1039) | 910 (748–1078) |
| | 9 (13.2) | 14 (19.7) |
| | 932 (838–1079) | 953 (859–1068) |
| | −0.58 (−1.16–−0.09) | −0.54 (−0.93–−0.2) |
| | 0.744 ± 0.07 | 0.751 ± 0.07 |
| | −0.97 ± 0.82 | −0.91 ± 0.75 |
| | 22 (19 to 25) | 22 (19 to 25) |
| | −0.16 ± 0.9 | −0.08 ± 0.8 |
| | 0.555 ± 0.07 | 0.568 ± 0.07 |
| | −0.52 ± 0.88 | −0.39 ± 0.80 |
| | 3.8 (3.0–5.1) | 3.7 (3.0–4.8) |
| | 12.4 (11.7–13.2) | 12.4 (11.8–13.4) |
No significant differences between BM-NE and usual care participants in any characteristic
Based on milk consumption, fracture history, family history of osteoporosis, lactose intolerance
n=54 (BM-NE), n= 57 (Usual Care)
Mg/day, adjusted by study dietician as described previously[36]
Abbreviations: BMC, Bone Mineral Content; BMD, Bone Mineral Density; BMI, Body Mass Index; BM-NE, Behavioral Modification and Nutritional Education; DXA, Dual Energy X-ray Absorptiometry; FMI, Fat Mass Index; LBMI, Lean Body Mass Index; LS, Lumbar Spine; RDA, Recommended Daily Allowance; WB, Whole Body
Dietary calcium intake over time in behavioral modification-nutritional intervention (BM-NE) compared to usual care (UC) groups2
| BM-NE Intervention | Usual Care | p-value | adjusted p-value | |
|---|---|---|---|---|
| 876 (735–1039) | 910 (748–1078) | 0.39 | -- | |
| 1008 (804–1164) | 967 (815–1093) | 0.34 | ||
| 1008 (841–1217) | 956 (779–1100) | 0.09 | ||
| 969 (806–1146) | 917 (750–1074) | 0.31 | 0.13 | |
| 937 (807–1088) | 903 (726–1059) | 0.35 | 0.27 | |
| 880 (772–1087) | 876 (758–1019) | 0.75 | 0.88 | |
| 951 (814–1126) | 897 (750–1079) | 0.24 | 0.17 |
Mg/day, adjusted by study dietician as described previously[36]
p-value represents pairwise comparison of raw dietary calcium intake at each visit
p-value represents group difference in calcium intake over time adjusted for age, sex, African American ancestry, and milk refusal
Median (inter-quartile range), all such values
Figure 2Median adjusted calcium intake in the usual care compared to behavioral modification-nutritional education (BM-NE) intervention group
Predicted calcium intake adjusted for age, sex, history of milk refusal, black racial group, BM-NE intervention*visit interaction. Calcium intake from food frequency questionnaire was adjusted by nutritionists to account for overestimation of calcium intake by participants.
* indicates significantly different from usual care, p<0.05
Figure 3Median whole body (A) and lumbar spine (B) bone mineral content and whole body (C) and lumbar spine (D) bone mineral density in the usual care compared to behavioral modification-nutritional education (BM-NE) intervention group
Predicted whole body and lumbar spine bone mineral content and bone mineral density adjusted for age, sex, height, LBMI, and black racial group. No significant effect of the BM-NE was observed at any of the study time points for any bone outcome.
Effect of time*calcium intake interaction on bone and body composition outcomes
| Beta Coefficient | 95% CI | P-value | |
|---|---|---|---|
| Calcium intake | −0.0004 | −0.04,0.04 | 0.98 |
| Calcium*6 month visit | 0.0001 | −0.04,0.04 | 0.99 |
| Calcium*12 month visit | 0.0124 | −0.03,0.56 | 0.57 |
| Calcium*24 month visit | 0.0035 | −0.05,0.06 | 0.91 |
| Calcium*36 month visit | 0.0652 | −0.01,0.14 | 0.08 |
| _cons | −986.1 | −1192.5,−779.5 | <0.0001 |
| Calcium intake | 0.0013 | −0.001,0.003 | 0.05 |
| Calcium*6 month visit | −0.0002 | −0.001,0.001 | 0.72 |
| Calcium*12 month visit | −0.0008 | −0.002,0.001 | 0.26 |
| Calcium*24 month visit | −0.0009 | −0.003,0.001 | 0.29 |
| Calcium*36 month visit | 0.0002 | −0.002,0.003 | 0.841 |
| _cons | −41.7 | −48.7,−34.6 | <0.0001 |
| Calcium intake | 0.0006 | −0.001,0.001 | 0.09 |
| Calcium*6 month visit | −0.0003 | −0.001,0.001 | 0.41 |
| Calcium*12 month visit | −0.0005 | −0.001,0.001 | 0.17 |
| | − | − | |
| | − | − | |
| Calcium*30 month visit | 0.0003 | −0.001,0.001 | 0.58 |
| Calcium*36 month visit | 0.0001 | −0.001,0.001 | 0.77 |
| _cons | 10.6 | 7.3,13.9 | <0.0001 |
| Calcium intake | 0.0003 | −0.001,0.001 | 0.21 |
| Calcium*6 month visit | −0.0001 | −0.001,0.001 | 0.57 |
| Calcium*12 month visit | −0.0002 | −0.001,0.001 | 0.27 |
| | − | − | |
| Calcium*36 month visit | 0.0002 | −0.001,0.001 | 0.57 |
| _cons | −0.2 | −2.5,2.1 | 0.86 |
additional covariates included sex, African American ancestry group, age, height, lean body mass
additional covariates included sex, African American ancestry group, age
Abbreviations: BMC, bone mineral content